Hormone Replacement Therapy (HRT) for oestrogen deficiency symptoms in postmenopausal women. The experience of treating women more than 65 years old is limited.
The goal of this randomized controlled trial is to test the efficacy of StrataMGT in the management of Genitourinary Syndrome of Menopause (GSM) compared to estrogen therapy.
The injectable ACTH gel medication Cortrophin Gel (repository corticotropin injection), first introduced in the U.S. in the 1950s, will now be relaunched by ANI Pharmaceuticals as a treatment for acute flare-ups in multiple sclerosis (MS) and other autoimmune conditions, following its approval by the FDA.
The FDA) has approved Bio-T-Gel, which is licensed by BioSante to Teva Pharmaceuticals USA, Inc. Bio-T-Gel is a testosterone gel...
Allergan plc announced that the Company has received approval from the FDA to market Aczone (dapsone) Gel, 7.5%, a new...
Galderma announced that it has received a Positive Opinion from 16 concerned European regulatory agencies for the market approval of...
BioDelivery Sciences International, Inc.( BDSI ) has announced that its Phase IIb clinical study assessing the efficacy and safety of...
Novan, Inc. announced the publication of positive efficacy and safety data from its completed B-SIMPLE 4 pivotal Phase III clinical study evaluating berdazimer gel, 10.3% for the treatment of molluscum in the peer-reviewed journal, JAMA Dermatology.